Decylubiquinone Inhibits Colorectal Cancer Growth Through Upregulating Sirtuin2
Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide.Decylubiquinone (DUb), a coenzyme Q10 analog, was reported to inhibit breast cancer growth and metastasis by us.However, the influence of DUb on CRC remains unclear.Herein, we found that DUb significantly inhibited CRC growth in the patient-derived xenograft (PDX